Filter your results
- 3
- 1
- 4
- 4
- 1
- 2
- 1
- 3
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationNature, 2021, 596 (7871), pp.276-280. ⟨10.1038/s41586-021-03777-9⟩
Journal articles
pasteur-03696844v1
|
||
|
SURVEILLANCE DES INFECTIONS HUMAINES PAR HANTAVIRUS EN FRANCE MÉTROPOLITAINE, 2012-2016Bulletin Epidémiologique Hebdomadaire - BEH, 2017, 23, pp.492-9
Journal articles
pasteur-01834340v1
|
||
|
Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and VaccinationViruses, 2022, Special Issue SARS-CoV-2 Research in France, 14 (7), pp.1491. ⟨10.3390/v14071491⟩
Journal articles
pasteur-04082742v1
|
||
|
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionEBioMedicine, 2021, 71, pp.103561. ⟨10.1016/j.ebiom.2021.103561⟩
Journal articles
hal-03500711v1
|